Bumetanide Injection
Product Images NDC 70748-323

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 70748-323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D36fe175 34a6 4627 8778 Da5f98c12391 01)

Chemical structure diagram of bumetanide showing a benzene ring with carboxylic acid (COOH), sulfonamide (SO2NH2), aniline (NH with butyl side chain), and phenoxy (OC6H5) substituents.*

FDA Label Image

Image 01 (D36fe175 34a6 4627 8778 Da5f98c12391 02)

Label for Bumetanide Injection, USP 1 mg/4 mL (0.25 mg/mL) injection for intravenous or intramuscular use. The 4 mL single dose vial is manufactured by Lupin Pharmaceuticals, Inc. It contains benzyl alcohol and includes storage instructions and preservative information. The label features a barcode and manufacturer address in India.*

FDA Label Image

Image 02 (D36fe175 34a6 4627 8778 Da5f98c12391 03)

Packaging label for Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) injection by Lupin Pharmaceuticals, Inc. The label indicates the product is for intravenous or intramuscular use, comes in a package of 10 single-dose 4 mL vials, and includes preservative benzyl alcohol 10 mg per mL. The labeler is Lupin Pharmaceuticals, Inc., Baltimore, Maryland, with manufacturing in India, under NDC 70748-323.*

FDA Label Image

Image 03 (D36fe175 34a6 4627 8778 Da5f98c12391 04)

Bumetanide Injection, USP 2.5 mg/10 mL (0.25 mg/mL) vial label for intravenous or intramuscular use. The label notes presence of benzyl alcohol and indicates a 10 mL multiple dose vial by Lupin Pharmaceuticals, Inc. It includes storage instructions, manufacturer Lupin Limited India, and a barcode with NDC 70748-323-02.*

FDA Label Image

Image 04 (D36fe175 34a6 4627 8778 Da5f98c12391 05)

Label for Bumetanide Injection, USP 0.25 mg/mL (2.5 mg/10 mL), an injection for intravenous or intramuscular use. The label shows the proprietary name Bumetanide, strength 2.5 mg/10 mL with concentration 0.25 mg/mL, and indicates multiple dose vials of 10 x 10 mL. Manufactured by Lupin Pharmaceuticals, Inc. Packaging includes storage instructions and preservatives.*

FDA Label Image

Image (D36fe175 34a6 4627 8778 Da5f98c12391 54 1)

Chemical structure diagram of Bumetanide, the active ingredient in BUMETANIDE injection. The diagram shows molecular bonds and functional groups characteristic of the bumetanide molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.